PEN (Penumbra) Total Operating Expense: $793 Mil (TTM As of Mar. 2026)


PEN Penumbra Inc PEN
89 GF Score
Price $316.43
GF Value $331.61
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Penumbra Total Operating Expense?

Penumbra PEN +0.22% 89 Total Operating Expense is $793 Mil as of Mar. 2026. GuruFocus rates PEN with a GF Score™ of 89/100 and a GF Value™ of $331.61 (Fairly Valued). The stock has 1 warning sign investors should review.

Penumbra's Total Operating Expense for the three months ended in Mar. 2026 was $215 Mil. Penumbra's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $793 Mil.

Penumbra Total Operating Expense Related Terms

Penumbra Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Penumbra's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Penumbra Total Operating Expense Chart

Penumbra Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 482.88 529.13 590.88 668.77 753.19

Penumbra Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 175.53 183.18 191.58 202.90 215.18
PEN
89GF Score
Penumbra Inc PEN
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Penumbra Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $793 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of $793 Mil mean?
Penumbra (PEN) has a Total Operating Expense of $793 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Penumbra and its competitors.
Is Penumbra's Total Operating Expense too high?
Penumbra's current Total Operating Expense is $793 Mil. Overall, Penumbra has a GF Score™ of 89/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Penumbra's Total Operating Expense compare to GMED and PODD?
Penumbra's Total Operating Expense of $793 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Penumbra and its competitors. Penumbra's current Total Operating Expense is $793 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Penumbra stock overvalued right now?
Based on GuruFocus' analysis, Penumbra (PEN) is currently considered Fairly Valued. The stock's GF Value™ is $331.61, compared to a current price of $316.43 — trading 4.6% below its estimated fair value. The current Total Operating Expense is $793 Mil. Penumbra's overall GF Score™ is 89/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Penumbra (PEN), the current Total Operating Expense is $793 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Penumbra (PEN) Overvalued in 2026?

Based on GuruFocus' analysis, Penumbra stock appears to be undervalued. The current stock price of $316.43 is trading 4.6% below its estimated GF Value™ of $331.61. GuruFocus considers Penumbra to be Fairly Valued.

Key valuation signals for PEN:

  • Total Operating Expense: $793 Mil
  • GF Value™: $331.61 vs. price of $316.43 (4.6% below fair value)
  • GF Score™: 89/100 with 1 warning sign

No single metric tells the full story. See the PEN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Penumbra Business Description

Other Exchanges 0P8:Germany
Address 1310 Harbor Bay Parkway, One Penumbra Place, Alameda, CA, USA, 94502
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.
89GF Score

Get the complete analysis for PEN

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$316.43
Price
$331.61
GF Value